Altre lingue Medigen Biotechnology Corp.

Azioni

3176

TW0003176004

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
38,75 ^TWD	+0,39%		+0,91%	-13,50%

29/03	Il Ministero della Salute e del Benessere approva il progetto collaborativo di terapia autologa con cellule T Gamma-Delta di Medigen Biotechnology Corp. e dell'Ospedale Chi Mei	CI
15/03	Medigen Biotechnology Corp. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

The Ministry of Health and Welfare Approves Collaborative Autologous Gamma-Delta T Cell Therapy Project by Medigen Biotechnology Corp. and Chi Mei Hospital	29/03
Taiwan MOHW Approves A New Version of the Collaborative Autologous Natural Killer Cell Therapy Project by Medigen Biotechnology Corp. and Changhua Christian Hospital	26/03
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Medigen Biotechnology Corp. Announces Appointment of Chieh-Liang Lin as Chief Scientific Officer	11/03
Medigen Biotechnology Corp. Applies to the Taiwan Food and Drug Administration for Phase I/Ii Clinical Trial Ofallogeneic Natural Killer Cells (Magicell-NK)	29/02
Medigen Biotechnology Corp. Announces That the Ministry of Health and Welfare Has Approved the Collaborative Autologous Gamma-Delta T Cell Therapy Project by the Company and Changhua Christian Hospital	16/02
Medigen Biotechnology Corp. Announces Signing of the Sales Cooperation Agreement for the New Drug OBP-301 in Japan	07/02
The Ministry of Health and Welfare Approves the Collaborative Autologous Gamma-Deltat Cell Therapy Project by Medigen Biotechnology Corp.And Taichung Tzu Chi Hospital	11/01
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11/11
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/08/21
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Medigen Biotechnology Corp.

Azioni

3176

TW0003176004

Altre lingue

Filtri